Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04311749 · ClinicalTrials.gov registry record
Expanded NIPT for Pregnancy Complications
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 70
- Enrollment target
NCT04311749: Completed study, sponsored by University of California, San Francisco.
NCT04311749 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04311749 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
Interventions
- GENETIC Expanded panel cell free DNA testing (non-invasive prenatal testing)
- GENETIC Placental biopsy
- GENETIC Umbilical cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2024-08-30 |
What the finished NCT04311749 record still lists
NCT04311749 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Expanded panel cell free DNA testing (non-invasive prenatal testing) is the first listed.
NCT04311749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04311749 about?
NCT04311749 is a clinical study titled "Expanded NIPT for Pregnancy Complications". This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
What is the current status of trial NCT04311749?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-02-12. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT04311749?
The interventions under investigation include: Expanded panel cell free DNA testing (non-invasive prenatal testing) (GENETIC), Placental biopsy (GENETIC), Umbilical cord blood (GENETIC).
Who is sponsoring clinical trial NCT04311749?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI